Literature DB >> 21045492

Cognitive profile and structural findings in Wilson's disease: a neuropsychological and MRI-based study.

Shantala Hegde1, Sanjib Sinha, Shobini L Rao, Arun B Taly, M K Vasudev.   

Abstract

BACKGROUND: Systematic studies on neuropsychological profile in patients with Wilson's disease (WD) are far and few. AIM: To examine the profile of cognitive deficits and their magnetic resonance imaging (MRI) findings in patients with WD. PATIENTS AND METHODS: Twelve confirmed patients of WD (age at onset and evaluation, 13.7±11.2 and 21.7±5.3 years, respectively; M-F ratio, 7:5) on de-coppering therapy constituted the study sample. Battery of neuropsychological tests measuring mental speed, motor speed, sustained attention, focused attention, verbal category fluency, verbal working memory, response inhibition, planning, concept formation, set-shifting ability, verbal and visual learning and memory were administered. Phenotypic details and observations on MRI of brain carried out within six months of neuropsychological assessment were documented.
RESULTS: Neuropsychological assessment elicited cognitive deficits in multiple domains in all but one patient, who had normal MRI. Percentage of patients in the deficit range in various domains included: motor speed: 73%; verbal working memory, sustained and focused attention: 50%; verbal learning: 42%; visuo-constructive ability, verbal memory, mental speed: 33%-34%; verbal fluency, set-shifting ability, visual memory, verbal memory: 25%-27%; and verbal recognition: 17%. MRI was normal in three patients, and revealed variable abnormalities in the remaining: cerebral atrophy in 3; brainstem atrophy in 2; signal changes in basal ganglia in 9; and brainstem signal changes in 5. None had subcortical white matter changes. Two patients with normal MRI showed cognitive deficits.
CONCLUSION: This study provides insight into the complex cognitive and brain changes observed on MRI in WD. Use of advanced MRI techniques in a larger cohort may improve understanding regarding functional and structural brain changes observed in similar disorders.

Entities:  

Mesh:

Year:  2010        PMID: 21045492     DOI: 10.4103/0028-3886.72172

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  15 in total

Review 1.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

2.  Neuropsychological functioning and health-related quality of life: pediatric acute liver failure study group results.

Authors:  Lisa G Sorensen; Katie Neighbors; Song Zhang; Christine A Limbers; James W Varni; Vicky L Ng; Robert H Squires; Estella M Alonso
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

3.  Altered large-scale functional brain networks in neurological Wilson's disease.

Authors:  Rixing Jing; Yongsheng Han; Hewei Cheng; Yongzhu Han; Kai Wang; Daniel Weintraub; Yong Fan
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

4.  Brain MRI in the Decision for Liver Transplantation in Pediatric Neurological Wilson's Disease.

Authors:  Catarina Pinto; Maria João Malaquias; Helena Pessegueiro Miranda; Teresa Temudo; Ermelinda Silva; Cristina Ramos; Marina Magalhães
Journal:  Mov Disord Clin Pract       Date:  2022-09-08

5.  Health Related Quality of Life and Neurocognitive Outcomes in the First Year after Pediatric Acute Liver Failure.

Authors:  Lisa G Sorensen; Katie Neighbors; Regina M Hardison; Kathleen M Loomes; James W Varni; Vicky L Ng; Robert H Squires; Estella M Alonso
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

6.  ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine-β-hydroxylase.

Authors:  Katharina Schmidt; Martina Ralle; Thomas Schaffer; Samuel Jayakanthan; Bilal Bari; Abigael Muchenditsi; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2018-10-19       Impact factor: 5.157

7.  Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease.

Authors:  Rakesh Jadav; Jitender Saini; Sanjib Sinha; Bhavanishankara Bagepally; S Rao; Arun B Taly
Journal:  Metab Brain Dis       Date:  2013-05-01       Impact factor: 3.584

8.  Predictors of caregiver burden in patients with neurologic Wilson disease.

Authors:  Peng Wu; Yanjun Zheng; Xiaolei Fan; Honghao Wang; Xiaoxue Deng; Bei Sun; Peng Huang; Shan Jin; Yonghua Chen; Yuancheng Bao
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

9.  Selective impairment of attentional networks of alerting in Wilson's disease.

Authors:  Yongsheng Han; Fangfang Zhang; Yanghua Tian; Panpan Hu; Bo Li; Kai Wang
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

10.  Which factors are associated with global cognitive impairment in Wilson's disease?

Authors:  Norberto Anízio Ferreira Frota; Egberto Reis Barbosa; Claudia Sellitto Porto; Leandro Tavares Lucato; Carla Rachel Ono; Carlos Alberto Buchpiguel; Alexandre Aluizio Costa Machado; Paulo Caramelli
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.